Updated Guidance on MDR Surveillance: MDCG 2022-4, Revision 2
Updated Guidance on MDR Surveillance: MDCG 2022-4, Revision 2
Regulatory Affairs Medical Devices EU MDR
Thursday, 27 June 2024
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter)
\
\
LinkedIn
\
\
WhatsApp
\
\
Copy link
\
\
Mail
On May 27th, 2024, the Medical Device Coordination Group (MDCG) released a second revision on the guidance on appropriate surveillance regarding the transitional provisions under Article 120 of the MDR with regard to devices covered by certificates according to the MDD or the AIMDD (MDCG 2022-4 Revision 2).
Play
Updated Guidance on MDR Surveillance: MDCG 2022-4, Revision 2
AI-generated audio
0:47
This second revision includes adjustments all over the document to align it to Regulation (EU) 2023/607 of the European Parliament and of the Council of 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices.
Discover more expert content
Previous
Regulatory Affairs
5 Mar 2025
Fifth revision to MDCG 2019-6 Guidance document released
MDCG 2019-6 Rev. 5: Questions and Answers on requirements relating to notified bodies.
Regulatory Affairs
9 Jul 2024
MDCG: First Revision on the Guidance on Standardisation for Medical Devices
MDCG 2021-05 Revision 1: Guidance on standardization for medical devices The scope of this...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Regulatory Affairs
29 Oct 2024
First Revision of MDCG 2021-25 Released
Application of MDR requirements to “legacy devices” and to devices placed on the market prior to...
Regulatory Affairs
23 Dec 2024
Revision of MDCG 2019-13 released
MDCG 2019-13 Rev.1: Guidance on sampling of MDR Class IIa / Class IIb and IVDR Class B / Class C...
Regulatory Affairs
5 Mar 2025
Fifth revision to MDCG 2019-6 Guidance document released
MDCG 2019-6 Rev. 5: Questions and Answers on requirements relating to notified bodies.
Regulatory Affairs
9 Jul 2024
MDCG: First Revision on the Guidance on Standardisation for Medical Devices
MDCG 2021-05 Revision 1: Guidance on standardization for medical devices The scope of this...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Regulatory Affairs
29 Oct 2024
First Revision of MDCG 2021-25 Released
Application of MDR requirements to “legacy devices” and to devices placed on the market prior to...
Regulatory Affairs
23 Dec 2024
Revision of MDCG 2019-13 released
MDCG 2019-13 Rev.1: Guidance on sampling of MDR Class IIa / Class IIb and IVDR Class B / Class C...
Regulatory Affairs
5 Mar 2025
Fifth revision to MDCG 2019-6 Guidance document released
MDCG 2019-6 Rev. 5: Questions and Answers on requirements relating to notified bodies.
Regulatory Affairs
9 Jul 2024
MDCG: First Revision on the Guidance on Standardisation for Medical Devices
MDCG 2021-05 Revision 1: Guidance on standardization for medical devices The scope of this...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe
